Pharmacological tools to mobilise mesenchymal stromal cells into the blood promote bone formation after surgery
Therapeutic approaches requiring the intravenous injection of autologous or allogeneic mesenchymal stromal cells (MSCs) are currently being evaluated for treatment of a range of diseases, including orthopaedic injuries. An alternative approach would be to mobilise endogenous MSCs into the blood, the...
Saved in:
Published in | npj Regenerative medicine Vol. 5; no. 1; p. 3 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
21.02.2020
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!